Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10646456 Methods of administering amantadine

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 13, 2018
Date of Patent
May 12, 2020
Patent Application Number
16188770
Patent Citations
‌
US Patent 10154971 Methods of administering amantadine
Patent Citations Received
‌
US Patent 11505593 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11535663 Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
‌
US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer
0
‌
US Patent 11459374 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11472861 Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
‌
US Patent 11485770 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11505594 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 12077570 Anti-VEGF protein compositions and methods for producing the same
0
‌
US Patent 11459373 Anti-VEGF protein compositions and methods for producing the same
‌
US Patent 11542317 Anti-VEGF protein compositions and methods for producing the same
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10646456
Patent Primary Examiner
‌
Sarah Pihonak

Find more entities like US Patent 10646456 Methods of administering amantadine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo